- Philips and Mass General Brigham: Advancing Patient Care
- Sensorion Receives Positive Recommendation from Data Monitoring Committee of SENS-501’s Audiogene Phase 1/2 Clinical Trial
- MG America Named Exclusive North American Distributor for Two Prominent Pharma Equipment Manufacturers
- Suj Mehta Elevates TekniPlex Healthcare as New CEO
- Seonix Bio Announces US Launch of SightScore, the First Commercially Available Clinical Polygenic Risk Score Testing Service for Glaucom
- KA Imaging’s Premium Dual-Energy Mobile System Now Available For Sale In Europe Reveal Mobi Pro Has Received the CE Mark
- Medtronic Amplifies AiBLE Ecosystem with CD Horizon™ ModuLeX™ Spinal System for Deformity Procedures
Medical Device News Magazine is a digital Publication Founded in 2008, and proudly located in the United States
Medical Device News Magazine delivers the latest updates from the medical device and biotechnology sectors. We take pride in offering high-quality, in-depth content, crafted by a team of experienced professionals. Our goal is to provide a unique perspective on the trends and innovations driving the future of medical technology. By reading our articles, you’re not only gaining exclusive industry insights but also becoming part of a community committed to advancing healthcare through groundbreaking technologies. Explore our content and consider partnering with us for advertising opportunities!
“Medical Device News: Essential Key Insights and Noteworthy Developments Shaping the Future”
Medtronic Extravascular ICD Global Clinical Trial Results Reinforce Device Safety and Effectiveness
Medtronic Extravascular ICD system is a first-of-its-kind implantable defibrillator, designed to avoid certain risks of traditional, transvenous ICDs because its lead (thin wire) is placed outside the heart and veins, under the sternum (breastbone). The system offers anti-tachycardia pacing (ATP), pause prevention pacing, and a device similar in size, shape, and battery longevity to transvenous ICDs. Using a minimally invasive approach, the device is implanted below the left armpit (in the left mid-axillary region).
Reflow Medical Introduces the coraCatheters™ Line and Expands into Complex Percutaneous Coronary Interventions (PCI)
The coraCatheters family of novel devices is the latest in the Reflow portfolio, which includes the Wingman™ and Spex™ Catheters. As the company makes its mark in the coronary space, they are expanding their sales team to support both current and future innovations.
Droplette Launches Droplette 2
The Second-Generation Patented Micro-Infuser Device is Smarter Than Ever, With Hardware and Software Updates to Create an Unrivaled Skincare Experience.
inHEART Receives CE Certification Under New MDR for Novel AI-Based Digital Twin of the Heart
inHEART solution creates digital 3D models of the heart with unprecedented anatomical details, allowing physicians to better plan and personalize cardiac ablation procedures.
Clinical Trials
Study Validates Lunit AI as a Game-Changer, Poised to Replace One Human Reader in Breast Cancer Screening
Utilizing Lunit INSIGHT MMG, an FDA-cleared and CE-marked AI solution for mammography analysis, this research backs AI’s potential to replace one human reader under Europe’s double reading guideline and underscores its capacity to alleviate the strain on radiologists.
MedAlliance Announces Enrollment of over 1,660 Patients in Landmark SELUTION DeNovo Study
SELUTION DeNovo Study is the largest DEB study ever initiated, involving up to 70 participating sites across 15 countries. Patients are randomized before any vessel preparation to reflect current medical practice and to reduce bias. The objectives of the study are to demonstrate non-inferiority at both one and five years, and superiority for target vessel failure (TVF) at five years.
Vitestro Starts Largest-scale Clinical Trial Globally for its Autonomous Blood Drawing Device, with Enrolment of First Patients in A.D.O.P.T.
Vitestro expects to obtain CE marking by the end of 2024. The first 350 patients have currently been enrolled the A.D.O.P.T. (Autonomous Optimization and Performance Tests for Blood Testing) Trial at study site Result Laboratorium in the Albert Schweitzer Hospital. Investigational partners, in addition to Result Laboratorium – Albert Schweitzer Hospital, are St. Antonius, OLVG Lab and Amsterdam UMC.
Biotechnology News
Our Experts – Byline Articles
Read Their Views & Share With a Colleague or Two!
Skin May Become the First Organ to Fulfill the Promise of Regenerative Medicine | By Dr. Ned Swanson – President & Chief Medical Officer of PolarityBio
The field of regenerative medicine may be on the cusp of an evolution, and due to the unique attributes of skin and wounds, the largest organ in the body may be emerging as a leader
Pinpointing the Invisible Source of Chronic Low Back Pain | By Brent Ness, CEO of Aclarion
Intense chronic low back pain (CLBP) is a global epidemic that plagues over 266 million people worldwide – we are not referring to the kind of sore back that you have after a long flight or weekend sleeping on your friend’s sofa, but rather the grinding, “drops you to your knees” pain that prevents you from going to work or school
Bioactive Precontoured Wedges: Redefining Deformity Correction in Foot & Ankle Surgery | By Scott Day, Vice President of Global Marketing & Business Development, NovaBone
A Catalyst for Change in Osteotomy Care
FDA Medical Device Updates
Comprehensive Insights into Medical Device & Biotechnology Company Mergers, Acquisitions & Funding
CroíValve Raises an €8M Series A Round
The funding will support a European Feasibility Study of the CroíValve Transcatheter Tricuspid DUO Coaptation Valve System.
Damae Medical Raises €5M in Series A Financing
The financial resources offered by this second round of financing of €5 million will enable the company to accelerate the commercial deployment of deepLive™ in Europe and to push the development of our product even further.
Enable Injections Announces $215 Million in Series C Financing
The funding from Magnetar will help enFuse continue to redefine intravenous drug delivery by meaningfully scaling development and commercialization efforts.
NaoX Technologies Raises €4.3 Million
NaoX was co-founded in 2018 by Hugo Dinh, a graduate from Ecole Polytechnique, and Michel Le Van Quyen, a research director at Inserm, respectively CEO and Chief Scientific Officer.
Market Reports
Advancements in Imaging
Hospitals In the News
Medical Device and Biotechnology Executives: Innovative Professionals on the Move and Making Waves in the Industry
Non-Profit News
Healthcare - Understanding the Business Side of the Industry and Its Implications
How to Generate More Patient Leads in 2023
Introduction Are you looking for ways to generate more patient leads in 2023? The healthcare industry is becoming increasingly competitive and it can be difficult
4 Employability Skills Every Healthcare Professional Needs to Thrive
In today’s rapidly transforming era, healthcare is witnessing unprecedented challenges at the hands of technology and the evolving environment. From novel viruses to advanced technological
Five Means To High-Quality Patient Care You Haven’t Thought Of
In the post-pandemic world, the healthcare industry is being pushed to the limits with demands for high-quality patient care. With all the strains they face,
How EHR Software Can Be a Game Changer for Your Healthcare Business
The Electronic Health Record EHR software is evolving to become a vital part of the healthcare industry by transforming how a patient’s information is stored, exchanged and organized in healthcare institutions or organizations.
